BIOMAT Database Logo BIOMAT Database Logo

Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man. 1978

T F Patton, and K J Himmelstein, and R Belt, and S J Bannister, and L A Sternson, and A J Repta

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014461 Ultracentrifugation Centrifugation with a centrifuge that develops centrifugal fields of more than 100,000 times gravity. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)

Related Publications

T F Patton, and K J Himmelstein, and R Belt, and S J Bannister, and L A Sternson, and A J Repta
Plasma levels and urinary excretion of methyl-GAG following iv infusion in man.
January 1981, Cancer treatment reports,
T F Patton, and K J Himmelstein, and R Belt, and S J Bannister, and L A Sternson, and A J Repta
Biliary excretion of platinum in a patient treated with cis-dichlorodiammineplatinum (II).
February 1985, Antimicrobial agents and chemotherapy,
T F Patton, and K J Himmelstein, and R Belt, and S J Bannister, and L A Sternson, and A J Repta
Atomic absorption spectrophotometry of free circulating platinum species in plasma derived from cis-dichlorodiammineplatinum(II).
June 1978, Clinical chemistry,
T F Patton, and K J Himmelstein, and R Belt, and S J Bannister, and L A Sternson, and A J Repta
Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II).
January 1979, Cancer treatment reports,
T F Patton, and K J Himmelstein, and R Belt, and S J Bannister, and L A Sternson, and A J Repta
Toxic effects of cis-dichlorodiammineplatinum(II) in man.
January 1979, Cancer treatment reports,
T F Patton, and K J Himmelstein, and R Belt, and S J Bannister, and L A Sternson, and A J Repta
Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.
January 1979, Cancer treatment reports,
T F Patton, and K J Himmelstein, and R Belt, and S J Bannister, and L A Sternson, and A J Repta
Cis-dichlorodiammineplatinum (II) (cis-platinum) and etoposide for patients with refractory lymphomas.
June 1982, Cancer treatment reviews,
T F Patton, and K J Himmelstein, and R Belt, and S J Bannister, and L A Sternson, and A J Repta
Atopic hypersensitivity to cis-dichlorodiammineplatinum(II) and other platinum complexes.
October 1975, Cancer research,
T F Patton, and K J Himmelstein, and R Belt, and S J Bannister, and L A Sternson, and A J Repta
Plasma levels of doxorubicin after IV bolus injection and infusion of the doxorubicin-DNA complex in rabbits and man. Comparison with free doxorubicin.
January 1982, Cancer chemotherapy and pharmacology,
T F Patton, and K J Himmelstein, and R Belt, and S J Bannister, and L A Sternson, and A J Repta
Iotroxamide studies in man--biliary iodine levels following bolus injection and slow infusion. Comparison with ioglycamide.
November 1980, Clinical radiology,
Copied contents to your clipboard!